Hetero-cellular interaction between cancer cells and stem cells in cancer metastasis
Tags: METASTASIS -- Abstracts; CELL interaction; CANCER cells
Related Articles
- Suppression of Tumor Metastasis by Adenoviral-Mediated MRP-1/CD9 Expression. // Molecular Therapy;May2004 Supplement 1, Vol. 9, p365
An abstract of the article "Suppression of Tumor Metastasis by Adenoviral-Mediated MRP-1/CD9 Expression," by Yi Lu, Jun Zhang and Bogdan Ceacareanu is presented.
- P38MAPK Induces Cell Surface a4 Integrin Downregulation to Facilitate erbB-2-Mediated Invasion. Ignatoski, Kathleen M. Woods; Grewal, Navdeep K.; Markwart, Sonja; Livant, Donna L.; Ethier, Stephen P. // Neoplasia;Mar/Apr2003, Vol. 5 Issue 2, p128
Focuses on a study which investigated the signaling pathways activated in human breast cancer cells and erbB-2-transformed human mammary epithelial cells. Materials and methods; Results; Discussion.
- Promiscuous Transcription of Vascular Endolithial Growth Factor and Survival of Tumors. Ellis, Lee M.; Gallick, Gary E. // JNCI: Journal of the National Cancer Institute;07/05/2000, Vol. 92 Issue 13, p1030
Editorial. Comments on an article published in the July 5, 2000, issue of the 'Journal of the National Cancer Institute,' by Essam A. Sheta et al, concerning cell-cell communication between human prostate cancer cell. Angiogenesis process; Recognition of vascular endothelial growth factor...
- Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens. Kalina, Tomas; Vaskova, Martina; Mejstrikova, Ester; Madzo, Jozef; Trka, Jan; Stary, Jan; Hrusak, Ondrej // BMC Cancer;2005, Vol. 5, p38
Background: Aberrant expression of myeloid antigens (MyAgs) on acute lymphoblastic leukemia (ALL) cells is a well-documented phenomenon, although its regulating mechanisms are unclear. MyAgs in ALL are interpreted e.g. as hallmarks of early differentiation stage and/or lineage indecisiveness....
- Abstracts of the 27th International West Coast Chromatin and Chromosomes Conference / R�sum�s de la 27
e Conf�rence internationale de la c�te Ouest sur la chromatine et les chromosomes. // Biochemistry & Cell Biology;Aug2006, Vol. 84 Issue 4, p658The article presents abstracts of medical research on chromatin and chromosomes. They include "Histone Modifications During H2A/H2B Exchange In Vivo," "Changes in H1-Chromatin Interactions During the Differentiation of Murine Erythroleukemia Cells," and "Multiple Roles for Histone H2A in...
- BAK linked to ocular surlace damage in animal studies. Kahook, Malik // Ophthalmology Times;1/15/2008, Vol. 33 Issue 2, p30
The article reports on the study conducted in an animal model with medication preserved with benzalkonium chloride (BAK) in Taormina, Italy. Researchers found that latanoprost with BAK caused a significant loss of cell-cell adhesion that can predispose patients to have ocular surface damage. It...
- Predicting behavior of melanoma. Newman, Laura // Dermatology Times;May2004, Vol. 25 Issue 5, p64
Presents a study on the identification of conventional diagnostic methods for melanoma according to research from New York. Inclusion of studies of molecular changes in DNA expression in cancer cells; Identification of cell-to-cell interactions; Changes in the levels of protein expression in...
- The matrix. Ananthaswamy, Anil // New Scientist;11/15/2008, Vol. 199 Issue 2682, p43
The article presents information on the nanotubes present in animal cells. Nanotubes are 50 to 200 nanometres thick hollow rivets used by organism to communicate very selectively over long range. According to researches, nanotubes may provide HIV with a network of secret tunnels that allow it to...
- Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction. Mlecnik, Bernhard; Sanchez-Cabo, Fatima; Pornpimol Charoentong; Bindea, Gabriela; Pag�s, Franck; Berger, Anne; Galon, Jerome; Trajanoski, Zlatko // BMC Genomics;2010 Supplement 1, Vol. 11, Special section p1
Cancer progression is a complex process involving host-tumor interactions by multiple molecular and cellular factors of the tumor microenvironment. Tumor cells that challenge immune activity may be vulnerable to immune destruction. To address this question we have directed major efforts towards...
